SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056248
Filing Date
2021-11-10
Accepted
2021-11-10 16:43:01
Documents
57
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xene-10q_20210930.htm   iXBRL 10-Q 2723577
2 EX-10.3 xene-ex103_9.htm EX-10.3 181707
3 EX-31.1 xene-ex311_7.htm EX-31.1 22875
4 EX-31.2 xene-ex312_10.htm EX-31.2 22918
5 EX-32.1 xene-ex321_6.htm EX-32.1 12334
6 EX-32.2 xene-ex322_8.htm EX-32.2 11920
  Complete submission text file 0001564590-21-056248.txt   7100421

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA xene-20210930.xsd EX-101.SCH 48073
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20210930_cal.xml EX-101.CAL 41297
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20210930_def.xml EX-101.DEF 116113
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20210930_lab.xml EX-101.LAB 338086
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20210930_pre.xml EX-101.PRE 238704
12 EXTRACTED XBRL INSTANCE DOCUMENT xene-10q_20210930_htm.xml XML 895832
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 211397397
SIC: 2834 Pharmaceutical Preparations